Issue 90, 2020

Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen

Abstract

Rhamnose and sTn antigen were co-conjugated to bovine serum albumin (BSA), a weakly immunogenic carrier protein, for cancer vaccine development. The immune responses against sTn have been significantly augmented with the involvement of Rha-specific antibodies to enhance antigen uptake.

Graphical abstract: Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen

Supplementary files

Article information

Article type
Communication
Submitted
02 Aug 2020
Accepted
12 Oct 2020
First published
12 Oct 2020

Chem. Commun., 2020,56, 13959-13962

Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen

H. Lin, H. Hong, J. Wang, C. Li, Z. Zhou and Z. Wu, Chem. Commun., 2020, 56, 13959 DOI: 10.1039/D0CC05263A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements